Mechanisms of action of coronary heart disease and chronic heart failure by Yixin Jianpi prescription with the concept of
10.3969/j.issn.1673-9701.2024.12.018
- VernacularTitle:益心健脾方
- Author:
Ruyi JIN
1
;
Qilan CHEN
1
Author Information
1. Department of Cardiovascular Disease, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou 310007, Zhejiang, China
- Publication Type:Journal Article
- Keywords:
Network pharmacology;
Homotherapy for heteropathy;
Coronary heart disease;
Chronic heart failure;
Molecular docking
- From:
China Modern Doctor
2024;62(12):79-84,87
- CountryChina
- Language:Chinese
-
Abstract:
Objective Network pharmacology was used to explore the mechanism of action of Yixin Jianpi prescription in the treatment of coronary heart disease and chronic heart failure.Methods With the help of traditional Chinese medicine systems pharmacology(TCMSP),traditional Chinese medicine integrated database(TCMID)and other databases combined with literature data to screen the active ingredient targets of Yixin Jianpi prescription,the human gene database(GeneCards),online mendelian inheritance in man(OMIM)and other databases were used to search for disease targets.The STRING platform combines Cytoscape software to construct a"component-target-disease"network diagram and protein interaction network.Gene ontology(GO)functionality and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway analysis using the DAVID database.The key components are taken and the target is molecularly docked with AutoDuck tools.Results 265 potential targets of Yixin Jianpi Prescription were obtained,and 106 of them were common targets of"homotherapy for heteropathy";The key active ingredients were quercetin,kaempferol,β-sitosterol,etc.and the core targets were SRC,AKT1,MAPK1,TP53,etc.Biological processes involve positive regulation of gene expression,negative regulation of apoptosis,signal transduction,etc.involving lipid and atherosclerosis,fluid shear stress,atherosclerosis and inflammatory response.Molecular docking verified the stable docking of key components quercetin and kaempferol with SRC,AKT1 and MAPK1 targets.Conclusion The study reveals the multi-component,multi-target,and multi-pathway mechanism of"homotherapy for heteropathy"of coronary heart disease and chronic heart failure by Yixin Jianpi prescription,and provides a basis for exploring its new clinical applications.
